Pregled bibliografske jedinice broj: 123545
Steroid diabetes in children with Crohn disease
Steroid diabetes in children with Crohn disease // Acta Medica Croatica, 56 (2002), 33-38 (podatak o recenziji nije dostupan, članak, stručni)
CROSBI ID: 123545 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Steroid diabetes in children with Crohn disease
Autori
Banac, Srđan ; Peršić, Mladen ; Cvijović, Katarina
Izvornik
Acta Medica Croatica (1330-0164) 56
(2002);
33-38
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
adverse effects; children; Crohn disease; glucocorticoids; steroid diabetes
Sažetak
Glucocorticoids may be useful as short-term palliative therapy for acute exacerbations of Crohn disease. When glucocorticoids are used longer than brief periods, even in moderate dosages, they can produce a variety of adverse effects, including steroid diabetes. Two boys were treated with methylprednisolone due to acute exacerbations of Crohn disease. After five and six weeks of continous oral administration of methylprednisolone, the boys developed steroid diabetes. Diabetic symptoms dominated the clinical presentation but there was no tendency towards diabetic ketoacidosis. Reduction of methylprednisolone dosage rather than insulin therapy resulted in better control of glycemia. Frequent blood glucose monitoring is recommended in children on prolonged therapy with glucocorticoids. Steroid diabetes experienced by reported cases may be a marker for the onset of diabetes in their adulthood.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE